CN Patent

CN101977923B — 抑制细胞生长的7-脱氮嘌呤核苷

Assigned to Czech Academy of Sciences CAS · Expires 2014-10-08 · 12y expired

What this patent protects

本发明提供了式I化合物及其盐，其中R 1 和R 2 具有如说明书所述的任意定义，以及含有所述化合物的组合物和使用所述化合物的治疗方法。

USPTO Abstract

本发明提供了式I化合物及其盐，其中R 1 和R 2 具有如说明书所述的任意定义，以及含有所述化合物的组合物和使用所述化合物的治疗方法。

Drugs covered by this patent

ruxolitinib-phosphate (RUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: CN101977923B
Jurisdiction: CN
Classification: —
Expires: 2014-10-08
Drug substance claim: No
Drug product claim: No
Assignee: Czech Academy of Sciences CAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.